Pharmacokinetics and Safety Study With Alfuzosin in Children and Adolescents With Elevated Detrusor Leak Point Pressure of Neuropathic Etiology

NCT00629720 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Urinary Bladder Neurogenic

Interventions

DRUG: alfuzosin (SL770499)

Sponsor

Sanofi